Researchers are exploring strategies to optimize t cell boosting for various vaccine regimens, including adenoviral and modified vaccinia ankara vaccines. This work appears to have implications for immunotherapy approaches to diseases such as cancer, hepatitis b, and respiratory viruses, as well as hiv and coronavirus. The goal of these efforts is to develop more effective vaccine strategies, potentially through combination approaches or next-generation vaccine designs.